首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Molecular Therapy

Molecular Therapy杂志,由Cell Press出版,于2000年创刊,Monthly,出版语言English,ISSN:1525-0016,E-ISSN:1525-0024。

投稿咨询
Molecular Therapy
Molecular Therapy
Molecular Therapy
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
11.4
CiteScore
17.9
期刊收录
SCI、SCIE

Molecular Therapy(中文译名:《分子疗法》),ISSN:1525-0016,EISSN:1525-0024,是Cell Press出版的国际性学术期刊,创刊于2000年,以Monthly形式稳定发行,2026年总发文量约369篇。该刊采用混合开放访问,学科归属为医学 - 生物工程与应用微生物。该刊是医学、生物工程与应用微生物领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达11.4,2025年期刊CiteScore为17.9,2025年期刊自引率约3.5%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Molecular Therapy长期聚焦医学、生物工程与应用微生物及相关产业的技术应用前沿,平均审稿周期约1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、生物工程与应用微生物领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、GERMANY (FED REP GER)、CHINA MAINLAND、France、Canada、Italy等为核心发文国家与地区;HARVARD UNIVERSITYUNIVERSITY OF PENNSYLVANIA、UNIVERSITY OF CALIFORNIA SYSTEM、UNIVERSITY OF MASSACHUSETTS SYSTEM、STATE UNIVERSITY SYSTEM OF FLORIDA、UNIVERSITY OF LONDON、UNIVERSITY OF NORTH CAROLINA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 GENETICS & HEREDITY 遗传学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区 1区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 GENETICS & HEREDITY 遗传学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区 1区 1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 GENETICS & HEREDITY 遗传学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区 1区 1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 10 / 180

94.7

学科:GENETICS & HEREDITY SCIE Q1 6 / 192

97.1

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 18 / 191

90.8

学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 3 / 180

98.61

学科:GENETICS & HEREDITY SCIE Q1 4 / 192

98.18

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 6 / 191

97.12

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 6 / 177

96.9

学科:GENETICS & HEREDITY SCIE Q1 5 / 192

97.7

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 10 / 195

95.1

学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 4 / 177

98.02

学科:GENETICS & HEREDITY SCIE Q1 3 / 192

98.7

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 5 / 195

97.69


中国学者近期发文

1
Native cell niche-inspired multiordernanoassemblies orchestrate integrated interaction networks to guide muscle regeneratio

Author:Lou, Peng; Wang, Yizhuo; Zhang, Yimeng; Zhou, Xiyue; Li, Lan; Liu, Shuyun; Wan, Meihua; Lu, Yanrong; Liu, Jingping

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 2081-2097. DOI: 10.1016/j.ymthe.2025.12.044

2
Mitochondrial citrate transport represents a metabolic liability in MYCN-amplified neuroblastom

Author:Chen, Chan; Bao, Qing; Huang, Hao; Wang, Liyuan; Jiang, Jue; Liu, Hudan; Wang, Yuan; Qing, Guoliang; Fang, Yingzhe

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 2482-2495. DOI: 10.1016/j.ymthe.2025.12.061

3
A synthetic hyperglycemia-sensing gene circuit enhances blood glucose homeostasis in diabetic mic

Author:Zhang, Yuan; Deng, Shuai; Zhu, Yanlun; Li, Xu; Deng, Jiani; Wang, Chengdong; Sun, Jianmin; Bao, Feixiang; Tang, Shibing; Ye, Haifeng; Chan, Hon Fai; Zhao, Hui

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 2236-2255. DOI: 10.1016/j.ymthe.2025.12.059

4
Basic enables selection-free efficient knockin of DNA in human T cell

Author:Wang, Kexin; Li, Xiaorui; Li, Jin; Yu, Zhuoying; Li, Pan; Xie, Yuyang; Liu, Jinxin; Huang, Honglin; Zhang, Shanshan; Ma, Wenju; Gao, Fei; Du, Xuguang; Wang, Jianxun; Capecchi, Mario R.; Wu, Sen

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 2309-2323. DOI: 10.1016/j.ymthe.2025.12.064

5
Intravenous administration of EXG110 resulted in substrate correction in Fabry mice and sustained enzyme activity in non-human primate

Author:Li, Shaoyong; Yu, Pengfei; Wang, Hong; Liu, Mingwen; Wang, Qingzeng; Li, Zhongwan; Chen, Shuyuan; He, Chentao; Zhan, Bryan Yue; Tong, Lucas Song; Shou, Xinyi; Luo, Jingjing; Jia, Xiaoyuan; Xin, Xin; Hu, Wei; Lu, Zhihong; Wang, Yigang; Ye, Guojie; Mao, Jianhua; Wu, Zhenhua

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 1997-2011. DOI:

6
A CD40-OX40 co-stimulatory circuit orchestrates protective CD4+T cell immunity in tuberculosi

Author:Zhang, Ximeng; Yang, Jing; Li, Fuxiang; Wang, Yu; Li, Zhaodong; Wang, Wenfei; Hu, Yunlong; Shi, Chenyan; Pan, Fan; Feng, Carl G; Wang, Yejun; Yang, Qianting; Chen, Xinchun; Cai, Yi

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 2468-2481. DOI: 10.1016/j.ymthe.2025.12.062

7
Allergen-specific immunotherapy with Der p 1/2 mRNA vaccines relieves house-dust-mite-induced allergic airway inflammation in a mouse mode

Author:Li, Junda; Ru, Yi; Yi, Xilian; Guan, Kai; Li, Xiaogang; Yin, Jia

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 2063-2080. DOI: 10.1016/j.ymthe.2025.12.065

8
CD96 as a therapeutic target for CAR T cell therapy in acute myeloid leukemi

Author:Gao, Xiaotong; Liu, Hailing; Li, Guokun; Zhou, Yali; Dong, Yan; Chen, Xiao; Fan, Wen; Li, Erbing; Wang, Sanmei; Luan, Qinyao; Zhang, Jing; Jin, Hui; Liao, Hui; Luo, Yizhou; Liu, Li; Qin, Weiwei; Ren, Jiangtao; Li, Jianyong; Fan, Lei

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 4, pp. 2201-2216. DOI: 10.1016/j.ymthe.2025.12.058

9
Dual-targeting CD133/PD-L1 CAR-T plus αPD-1 overcomes immunosuppressive microenvironment and enhanced by radiation pre-conditionin

Author:Yao, Zhuoran; Kang, Kai; Li, Pei-Heng; Yin, Limei; Tong, Ruizhan; Yi, Linglu; Song, Yonghong; Luo, Ren; Wu, Yijun; Liu, Shanghai; Peng, Zichong; Mo, Xianming; Wang, Wenbo; Xue, Jianxin; Lu, You

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1483-1502. DOI: 10.1016/j.ymthe.2025.12.068

10
Gene therapy for Bietti crystalline corneoretinal dystrophy: A phase 1/2 clinical tria

Author:Yang, Liping; Xing, Dongjun; Zhang, Jinlu; Liu, Boshi; Jiang, Xiaoshuang; Chen, Shaohong; Li, Wang; Qu, Baoyuan; Qiao, Jing; Feng, Xuefeng; Jia, Haicun; Hu, Xianjun; Yu, Shicheng; Jia, Ruixuan; Wang, Likun; Mahajan, Vinit B.; Dou, Hongliang; Lu, Fang; Li, Xiaorong

Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1743-1755. DOI: 10.1016/j.ymthe.2026.01.005


在线咨询

Molecular Therapy

国际简称:MOL THER参考译名:分子疗法

年发文量:369 CiteScore:17.9 是否预警:否 Gold OA文章占比:35.37% 研究类文章占比:79.40%

杂志社联系方式:CELL PRESS, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139

Molecular Therapy